Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study

Background: Since the association of homocysteine and clinical results of observational studies are controversial on non-alcoholic fatty liver related disease, we compute the two-sample Mendelian Randomization (MR) study.Objective: To evaluate whether the plasma level of homocysteine has an effect o...

Full description

Bibliographic Details
Main Authors: Pengcheng Chen, Ze Yang, Lingyun Guo, Yingfei Huang, Jingjia Li, Xin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.1083855/full
_version_ 1811314383183151104
author Pengcheng Chen
Ze Yang
Ze Yang
Lingyun Guo
Lingyun Guo
Yingfei Huang
Yingfei Huang
Jingjia Li
Xin Chen
Xin Chen
Xin Chen
author_facet Pengcheng Chen
Ze Yang
Ze Yang
Lingyun Guo
Lingyun Guo
Yingfei Huang
Yingfei Huang
Jingjia Li
Xin Chen
Xin Chen
Xin Chen
author_sort Pengcheng Chen
collection DOAJ
description Background: Since the association of homocysteine and clinical results of observational studies are controversial on non-alcoholic fatty liver related disease, we compute the two-sample Mendelian Randomization (MR) study.Objective: To evaluate whether the plasma level of homocysteine has an effect on the risk of Non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and Cirrhosis after its progress, we investigated the causal relationships between plasma homocysteine and the three non-alcoholic fatty liver related diseases mentioned above.Design and methods: Summary estimates were elicited from the inverse-variance weighted (IVW) method through 12 single nucleotide polymorphisms (SNPs) which related to the plasma homocysteine, the SNPs were obtained from a large genome-wide association studies (GWAS) of 44,147 European participants. And the summary statistics for the latest and largest GWAS datasets for NAFLD (307576 in total and 1,578 cases), NASH (309055 in total and 99 cases) and Cirrhosis (306145 in total and 826 cases) were collected from Ristey FinnGen website where the association of genetic variations with blood metabolite levels was conducted using comprehensive metabolite profiling. The study was performed through two-sample MR method.Results: The result indicated that the plasma homocysteine is not significantly associated with NAFLD, and its progression, NASH and Cirrhosis.Conclusion: The evidence in this study is quite deficient to support the causal association of the individual plasma homocysteine with NAFLD, NASH and Cirrhosis, the putative of associations is not exist.
first_indexed 2024-04-13T11:11:51Z
format Article
id doaj.art-29b031d737964dfca8ea7fae93cc98df
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-04-13T11:11:51Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-29b031d737964dfca8ea7fae93cc98df2022-12-22T02:49:06ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2022-12-01910.3389/fmolb.2022.10838551083855Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization studyPengcheng Chen0Ze Yang1Ze Yang2Lingyun Guo3Lingyun Guo4Yingfei Huang5Yingfei Huang6Jingjia Li7Xin Chen8Xin Chen9Xin Chen10School of Electronics and Information Engineering, Institute of Big Data and Artificial Intelligence in Medicine, Taizhou University, Taizhou, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Biochemistry and Cancer Medicine, International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Biochemistry and Cancer Medicine, International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, ChinaDepartment of Biochemistry and Molecular Biology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Biochemistry and Cancer Medicine, International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, ChinaHuman Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai, ChinaSchool of Electronics and Information Engineering, Institute of Big Data and Artificial Intelligence in Medicine, Taizhou University, Taizhou, ChinaSchool of Medicine, Institute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou, ChinaJoint Institute for Genetics and Genome Medicine, Zhejiang University and University of Toronto, Zhejiang University, Hangzhou, ChinaBackground: Since the association of homocysteine and clinical results of observational studies are controversial on non-alcoholic fatty liver related disease, we compute the two-sample Mendelian Randomization (MR) study.Objective: To evaluate whether the plasma level of homocysteine has an effect on the risk of Non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and Cirrhosis after its progress, we investigated the causal relationships between plasma homocysteine and the three non-alcoholic fatty liver related diseases mentioned above.Design and methods: Summary estimates were elicited from the inverse-variance weighted (IVW) method through 12 single nucleotide polymorphisms (SNPs) which related to the plasma homocysteine, the SNPs were obtained from a large genome-wide association studies (GWAS) of 44,147 European participants. And the summary statistics for the latest and largest GWAS datasets for NAFLD (307576 in total and 1,578 cases), NASH (309055 in total and 99 cases) and Cirrhosis (306145 in total and 826 cases) were collected from Ristey FinnGen website where the association of genetic variations with blood metabolite levels was conducted using comprehensive metabolite profiling. The study was performed through two-sample MR method.Results: The result indicated that the plasma homocysteine is not significantly associated with NAFLD, and its progression, NASH and Cirrhosis.Conclusion: The evidence in this study is quite deficient to support the causal association of the individual plasma homocysteine with NAFLD, NASH and Cirrhosis, the putative of associations is not exist.https://www.frontiersin.org/articles/10.3389/fmolb.2022.1083855/fullhomocysteineNAFLDNASHCirrhosismendelian randomization
spellingShingle Pengcheng Chen
Ze Yang
Ze Yang
Lingyun Guo
Lingyun Guo
Yingfei Huang
Yingfei Huang
Jingjia Li
Xin Chen
Xin Chen
Xin Chen
Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
Frontiers in Molecular Biosciences
homocysteine
NAFLD
NASH
Cirrhosis
mendelian randomization
title Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
title_full Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
title_fullStr Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
title_full_unstemmed Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
title_short Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
title_sort effects of homocysteine on nonalcoholic fatty liver related disease a mendelian randomization study
topic homocysteine
NAFLD
NASH
Cirrhosis
mendelian randomization
url https://www.frontiersin.org/articles/10.3389/fmolb.2022.1083855/full
work_keys_str_mv AT pengchengchen effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT zeyang effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT zeyang effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT lingyunguo effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT lingyunguo effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT yingfeihuang effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT yingfeihuang effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT jingjiali effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT xinchen effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT xinchen effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy
AT xinchen effectsofhomocysteineonnonalcoholicfattyliverrelateddiseaseamendelianrandomizationstudy